Skip to content

Clinical trials

Phase 4 Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 4 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20151
20192
20211
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Not yet recruiting3
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anhui Provincial Cancer Hospital1
Chifeng Municipal Hospital1
China Medical University, China1
Fox Chase Cancer Center1
Genentech, Inc.1
Guangdong Association of Clinical Trials1
Jiangsu Simcere Pharmaceutical Co., Ltd.1
Lisa Sanderson Cox, PhD1
Peking Union Medical College Hospital1
Pharmacosmos A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma12
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Hepatocellular2
Carcinoma, Renal Cell2
Esophageal Neoplasms2
Head and Neck Neoplasms2
Hypopharyngeal Neoplasms2
Kidney Neoplasms2
Laryngeal Neoplasms2
Leukemia2

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.